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Abstract
Background: Obstructive sleep apnoea is a common disorder with under-rated clinical impact, which is increasingly
being recognised as having a major bearing on global disease burden. Men are especially vulnerable and become a
priority group for preventative interventions. However, there is limited information on prevalence of the condition in
Australia, its co-morbidities, and potential risk factors.
Methods: We used data from 13,423 adult men included in the baseline wave of Ten to Men, an Australian national
study of the health of males, assembled using stratified cluster sampling with oversampling from rural and regional
areas. Those aged 18–55 years self-completed a paper-based questionnaire that included a question regarding health
professional-diagnosed sleep apnoea, physical and mental health status, and health-related behaviours. Sampling
weights were used to account for the sampling design when reporting the prevalence estimates. Odds ratios were
used to describe the association between health professional-diagnosed sleep apnoea and potential correlates while
adjusting for age, country of birth, and body-mass index (BMI).
Results: Prevalence of self-reported health professional-diagnosed sleep apnoea increased from 2.2 % in age 18–25
years to 7.8 % in the age 45–55 years. Compared with those without sleep apnoea, those with sleep apnoea had
significantly poorer physical, mental, and self-rated health as well as lower subjective wellbeing and poorer
concentration/remembering (p < 0.001 for all). Sleep apnoea was significantly associated with older age (p < 0.001),
unemployment (p < 0.001), asthma (p = 0.011), chronic obstructive pulmonary disease/chronic bronchitis (p = 0.002),
diabetes (p < 0.001), hypercholesterolemia (p < 0.001), hypertension (p < 0.001), heart attack (p < 0.001), heart failure
(p < 0.001), angina (p < 0.001), depression (p < 0.001), post-traumatic stress disorder (p < 0.001), other anxiety disorders
(p < 0.001), schizophrenia (p = 0.002), overweight/obesity (p < 0.001), insufficient physical activity (p = 0.006), smoking
(p = 0.005), and high alcohol consumption (p < 0.001).
Conclusion: Health professional-diagnosed sleep apnoea is relatively common, particularly in older males. Associations
between sleep apnoea and cardiovascular, metabolic, respiratory, and psychiatric disorders have important
clinical and public health implications. As men are especially vulnerable to sleep apnoea as well as some of its
chronic co-morbidities, they are potentially a priority group for health interventions. Modifiable lifestyle related
factors such as smoking, alcohol consumption, level of physical activity and BMI are possible key foci for interventions.
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Background
Chronic respiratory disorders contribute significantly to
the global burden of disease, the recognition of which
prompted their inclusion among the four priorities of
the 2008–2013 World Health Organization’s action plan
on non-communicable diseases [1]. Chronic obstructive
pulmonary disease (COPD) is the 4th leading cause of
death, and others such as asthma are increasing in
prevalence affecting hundreds of millions at some stage
in their lives [2], while obstructive sleep apnoea (the
prevalence of the other type of sleep apnoea, i.e., central
sleep apnoea is very low in the population [3–5]) is also
a common but under-diagnosed chronic respiratory dis-
order [6–8]. It is increasingly being recognised as having
a significant impact on global burden of disease [9].
However, the evidence on the prevalence and as-
sociations of obstructive sleep apnoea in Australian (and
New Zealand) populations are limited [10–14]. A recent
study showed that one in ten Australians suffer from un-
diagnosed obstructive sleep apnoea [13]; in the males
aged 40–69 years this could be as high as 49 % and in
males aged >70 years, as high as 62 % [10]. It is becom-
ing a major public health concern with its increasing
prevalence and complications [9, 15–18].
Most advances in knowledge of obstructive sleep apnoea
have taken place only recently [19]; it is now suggested
that it may overlap with other chronic respiratory diseases;
a substantial overlap occurs between obstructive sleep
apnoea and COPD or asthma [20, 21]. The prevalence of
obstructive sleep apnoea varies in different populations
and different age groups, becoming markedly increased in
older age [22, 23]. It is commoner in obese individuals, as
well as in those with underlying comorbidities (such as
cardiovascular diseases, cerebrovascular diseases, and
metabolic abnormalities), people with a family history of
obstructive sleep apnoea, and those with anatomically
compromised upper airways. Men are more likely to
develop obstructive sleep apnoea and the diseases that it
complicates [9, 17, 23, 24]. There is, however, a dearth of
evidence on prevalence of obstructive sleep apnoea and its
co-morbidities in Australian men.
Using cross-sectional data from the baseline wave of
Ten to Men (The Australian Longitudinal Study on Male
Health) we aimed to describe the prevalence of self-
reported, doctor-/health professional- diagnosed sleep ap-
noea (hereafter referred to as sleep apnoea) and its overlap
with other chronic respiratory diseases, its association
with measures of health status and quality of life, and
potential correlates among Australian men.
Methods
Study design and setting
Ten to Men is a longitudinal cohort study of Australian
males aged between 10 and 55 years at the time of
recruitment (October 2013 to July 2014). Participants
were recruited from major cities as well as regional and
rural areas. The target population was all Australian
male citizens or permanent residents living in private
dwellings except those residing in areas classified as
remote or very remote.
Sample and sampling process
We used multi-stage stratified cluster sampling with
oversampling of regional areas to increase their repre-
sentation within the cohort. We approached 104,884
dwellings, of which 32 % met eligibility criteria. Of these,
13,697 (41 %) households returned usable data. Of the
45,510 males confirmed as meeting eligibility criteria,
15,988 (35 %) returned usable data. The setting, design,
sampling, study instruments, data collection process,
and participants’ characteristics of the Ten to Men study
is described elsewhere in this issue [25].
Study instruments
Adult participants answered a self-completed paper-
based questionnaire, a copy of which is available at the
Ten to Men website [26]. The questionnaire sought
details of the participants’ socio-demographic character-
istics, physical and mental health status, health-related
behaviours, family and social life, and health service use.
Wherever possible, the items were from validated scales
or questions used in other large health studies.
Data collection
Interviewers made up to three attempts (including at
least once at a weekend) to contact each household and
ascertain the presence of eligible males. A study pack,
including consent forms and questionnaires, was left for
each eligible individual in a household, which were col-
lected about a week later.
Definitions
We defined sleep apnoea as self-reported, doctor-or other
health professional- diagnosed sleep apnoea during life.
This was based on the question “Has a doctor or other
health professional ever told you that you had this condi-
tion? (Sleep apnoea)”. We used the same question to de-
fine the other chronic respiratory diseases (asthma, COPD
(“emphysema or chronic obstructive pulmonary disease”),
and chronic bronchitis).
Self-rated health was defined using the question “In
general, would you say your health is excellent/very
good/good/fair/poor” from the Short Form 12 (SF12)
[27]. Cognition was assessed by the response to the ques-
tion “Do you have difficulty remembering or concentrat-
ing?” taken from the Washington Group on Disability
Statistics’ Short set of Questions on Disability [28]. We
used the items of the SF-12 and Personal Wellbeing Index
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for Adults (English PWI-A, 4th edition) [29] to measure
participants’ physical and mental health and their subjective
wellbeing, respectively. Presence/absence of non-respiratory
co-morbidities (eczema, diabetes, high cholesterol, high
blood pressure, heart attack, heart failure, angina, stroke,
depression, post-traumatic stress disorder, other anxiety
disorders, schizophrenia, and cancer) was ascertained in
the same manner as for sleep apnoea using the same ques-
tion. As this paper is exploratory in nature, we included all
reported cardiovascular, metabolic, respiratory, and hyper-
sensitivity disorders as well as cancer in the analysis of cor-
relates. We used self-reported height and weight to derive
body-mass index (BMI). Level of physical activity was
assessed using the Active Australia survey [30] and sitting
time by questions on time spent sitting on work and non-
work days [31].
Statistical methods
Stata SE 13.1 (Stata Corp LP, College Station, TX, USA)
was used for data analysis. When estimating prevalence,
we accounted for the multi-stage sampling, stratification
and selection probabilities (including varying response
fractions by primary sampling unit) by using Stata’s
“survey” commands and sampling weights [32]. For asso-
ciations between sleep apnoea and other characteristics,
no account was taken of the clustering, stratification and
sampling weights [32]. We compared the distribution of
other variables among those with and without sleep
apnoea using bivariate statistics (χ2 test and t-test). We
used logistic regression to estimate crude odds ratios to
measure associations between possible correlates and
sleep apnoea, and odds ratios adjusted for the possible
confounding effects of age, country of birth, and BMI.
Because the prevalence of sleep apnoea was less than
10 %, the prevalence odds ratios are reasonably accurate
estimates of prevalence ratios.
Results
Prevalence of sleep apnoea and overlap with other
chronic respiratory disorders
Of the 13,423 respondents, 710 reported as being diag-
nosed to have sleep apnoea by a doctor or another health
professional. The prevalence of sleep apnoea increased
with age from 2.0 % (95 % CI 1.4 %-2.9 %) in those aged
18–25 years to 3.7 % (95 % CI 2.8 %–4.8 %), 6.6 % (95 %
CI 5.6 %–7.8 %), and 7.8 % (95 % CI 6.7 %–9.0 %) in those
aged 26–35, 36–45, and 46–55 years, respectively. Sleep
apnoea without other comorbid chronic respiratory disor-
ders increased from 1.4 % in 18–25 years age-group to
6.1 % in 46–55 years age-group (Fig. 1). Combination of
sleep apnoea and asthma increased from 0.6 % in the
youngest to 1.2 % in the oldest age-group. The overlap of
sleep apnoea and COPD/chronic bronchitis was relatively
low, occurring only in those aged over 35 years. The
proportion with sleep apnoea and both above other condi-
tions was also very low (<0.1 % in all ages). Of those with
sleep apnoea, 14.2 % had concurrent asthma but only
0.01 % and 0.02 %, respectively, had concurrent COPD/
Chronic bronchitis and both asthma and COPD/Chronic
bronchitis.
The impact of sleep apnoea on health and wellbeing
Men with doctor-/health professional- diagnosed sleep
apnoea were more likely to report fair or poor health
status and difficulty in remembering or concentrating
than those without sleep apnoea (Table 1). Those with
sleep apnoea also had lower SF-12 physical health and
mental health summary scores as well as subjective well-
being scores compared with those without sleep apnoea.
Correlates of sleep apnoea
Compared with those aged 18–25 years, the association
between doctor-/health professional- diagnosed sleep ap-
noea and age showed a 1.6, 2.4, and 3.1 fold increased
odds, respectively, in those aged 26–35, 36–45, and 46–
55 years (Table 2). Although being born in an Asian
country had significantly lower odds of sleep apnoea in
the univariate analysis, this was no longer significant
when adjusted for age and BMI. Marital status and level
of education were not significantly associated with sleep
apnoea. Significantly more men with sleep apnoea
(11.0 %) were neither working nor looking for work
compared with those without sleep apnoea (5.6 %).
Among those who were employed, the number of hours
worked and shift work did not significantly differ be-
tween sleep apnoea and non-sleep apnoea groups.
Those with doctor-/health professional- diagnosed sleep
apnoea had significantly higher odds of a number of co-
morbidities (Table 3). The means (and standard devia-
tions) of the total number of lifetime chronic respiratory
diseases, cardiovascular or metabolic diseases, and psychi-
atric disorders in those with and without sleep apnoea
were 0.4 (0.6) vs 0.3 (0.5), 0.9 (1.2) vs 0.4 (0.7), and 0.8
(1.0) vs 0.3 (0.7), respectively (p < 0.001 for all). Sleep
apnoea group had significantly increased odds of all co-
morbidities included in univariate analyses (Table 3),
and all these associations with the exception of stroke
and cancer remained significantly high after adjusting
for age, country of birth and BMI. Sleep apnoea was as-
sociated with a 4.5 fold increased odds of heart failure
and over 2 fold increased odds of psychiatric disorders,
heart attack, angina, and diabetes. The association be-
tween higher BMI and sleep apnoea remained significant
after adjusting for country of birth and age. The strength
of this association consistently increased from OR 1.7 in
the overweight group to OR 10.3 in the morbidly obese
(Obesity III) group.
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Insufficient physical activity and sitting time significantly
increased the odds of doctor-/health professional- diag-
nosed sleep apnoea (Table 4). Each one hour increase in
sitting time per day was associated with an increased odds
of 1.04 for sleep apnoea (95 % CI 1.02, 1.07; p < 0.001).
This odds remained significantly increased after adjusting
for age, country of birth and BMI (OR 1.03; 95 % CI 1.005,
1.06; p = 0.023). When the average sitting time was dichot-
omised as less than 6 h vs. 6 h or more [33], the odds of
sleep apnoea for those with more sitting time increased by
1.2 fold. Despite the significantly increased odds of sleep
apnoea when being an ex-smoker and a current smoker,
the strength of association between sleep apnoea and
lifetime smoking exposure showed no discernible pat-
tern across different levels of lifetime smoking exposure
(Table 4). The association between sleep apnoea and
high alcohol use months was also significant.
Discussion
The estimated population prevalence of doctor-/health
professional- diagnosed sleep apnoea among Australian
men aged 18–25 years to 46–55 years increased from
Fig. 1 Lifetime prevalence of sleep apnoea and other chronic respiratory diseases adjusted for the sampling design
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2.0 % to 7.8 %. Men with sleep apnoea had poorer
mental, physical, and self-rated health as well as low
subjective wellbeing and difficulty in concentration or
remembering. Presence of thirteen of the fifteen co-
morbidities examined were significantly increased with
sleep apnoea, as were insufficient physical activity, sitting
time, smoking, and high alcohol consumption.
Our study has several limitations. While it was de-
signed to be representative of the Australian male popu-
lation aged 10–55 years, the response fraction was low.
Although the sampling weights we used can account to
some extent for non-response, bias is still possible when
estimating population prevalence. The ‘sleep apnoea’ def-
inition we used did not discriminate between obstructive
vs. central sleep apnoea. Therefore, it is difficult to com-
pare our findings directly with previous studies that are
predominantly on obstructive sleep apnoea. However, as
the population prevalence of central sleep apnoea is
known to be very low [3–5], our definition is unlikely to
have a major effect on our findings. The cross sectional
associations identified in our study do not allow any
conclusions about causation or temporality. In addition,
there is also the possibility that our inability to accur-
ately determine whether the reported doctor-/health
professional- diagnosed sleep apnoea is being treated
might have introduced a bias we cannot account for as
there are some evidence that treatment of obstructive
sleep apnoea can help better control some co-morbidities
[34–36]. However, we do not expect this to be a major
limitation as the determination of both sleep apnoea and
the co-morbidities were based on ‘ever-having’ the disease
rather than being a current event. We did not objectively
measure sleep apnoea or other co-morbidities, which
are likely to have influenced the prevalence estimates
as well as the associations between sleep apnoea and
co-morbidities. Although we used the variable ‘country
of birth’ as a crude proxy for ethnicity in adjusting the
odds ratios for associations, it may not necessarily be a
reliable marker of ethnicity. Furthermore, our study
also lacked some key indices of sleep apnoea burden
such as sleepiness and motor vehicle crashes.
The age-specific prevalence of sleep apnoea in our study
is much lower than both the age-specific [12, 37, 38] and
age-standardised [13] prevalence of obstructive sleep ap-
noea that has been reported in other previous studies. As
some people with sleep apnoea can be asymptomatic, and
as only those who are symptomatic would generally seek
treatment leading to diagnosis by a health professional,
the proportion of health professional-diagnosed sleep
apnoea tends to be less than the actual population
prevalence at any given time. Therefore, the ‘self-reported
doctor-/health professional- diagnosed’ definition of sleep
apnoea used in our study compared with the sleep
measurement-based objective definitions used in the
above studies is likely to have led to lower estimate in
our study, reflecting under-reporting related to under-
diagnosis of obstructive sleep apnoea, which has been
found by others to be highly prevalent [13]. The preva-
lence of 7.8 % among those aged 46–55 years in our
study is also lower than 11.2 % reported for previously
diagnosed obstructive sleep apnoea in another cohort
of Australian men aged >40 years, likely due to inclu-
sion of comparatively older men in that cohort (includ-
ing those aged >70 years) [10]. Given this gradual
increase in the sleep apnoea prevalence with advancing
age, it would be important to study the older age groups
further to determine the prevalence among them and
resulting burden of disease. Studies on prevalence and
co-morbidities among females will also provide evi-
dence needed to better plan the possible preventative
interventions.
Prevalence of concurrent asthma or COPD among
those with doctor-/health professional- diagnosed sleep
apnoea was lower in our study than what has been pre-
viously reported for those with obstructive sleep apnoea
[39–42]. This difference could be explained by the par-
ticipants in those studies being older than our sample on
the average, as most chronic respiratory diseases in-
crease with age [43–45]. Lower prevalence in our study
may also be due to possible under-reporting resulting
















Excellent/very good/good 524 (74.3 %) 11669 (92.0 %) <0.001a
Fair/Poor 181 (25.7 %) 1009 (8.0 %)
Difficulty in remembering or concentrating
No difficulty 365 (51.8 %) 8736 (69.2 %) <0.001a
Some difficulty 282 (40.1 %) 3485 (27.6 %)
A lot of difficulty or cannot
do at all




50.0 (9.9) 54.2 (7.1) <0.001b
SF-12 Mental Component
Score
46.3 (10.6) 50.1 (9.1) <0.001b
Wellbeing
Subjective Wellbeing Score 63.6 (19.2) 70.8 (16.9) <0.001b
aBased on χ2 test
bBased on t test
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from the use of aforementioned definition for sleep ap-
noea and other diseases. If this lower prevalence does re-
flect under-diagnosis, it could indicate an increase in
future burden of the disease as sleep apnoea concurrent
with asthma or COPD leads to higher morbidity and
mortality [41, 46] and underdiagnosed diseases usually
present later with more complications.
Our results confirm the previously reported positive
associations between obstructive sleep apnoea and
ageing [14, 37, 47–49] and BMI [8, 50–52]. However,
our results on the positive association between sleep ap-
noea and heart failure are in contrast to the recent find-
ings from the Atherosclerosis Risk in the Communities
Study and the Sleep Heart Health Study [52] as well as
the Osteoporotic Fractures in Men Study [53], which
showed no association between obstructive sleep apnoea/
sleep-disordered breathing and heart failure. Those studies
were on older men, and therefore, are not comparable
Table 2 Associations between socio-demographic characteristics and sleep apnoea
Characteristic Lifetime doctor- or other health
professional- diagnosed sleep apnoea







18–25 years 48 (2.2 %) 2219 (100.0 %) 1.0 1.0
26–35 years 112 (3.6 %) 3158 (100.0 %) 1.7 (1.2, 2.3) 0.004 1.6 (1.1, 2.4) 0.016
36–45 years 246 (6.0 %) 4095 (100.0 %) 2.9 (2.1, 4.0) <0.001 2.4 (1.6, 3.4) <0.001
46–55 years 304 (7.7 %) 3951 (100.0 %) 3.8 (2.8, 5.1) <0.001 3.1 (2.1, 4.4) <0.001
Country of birth
Australia 584 (5.7 %) 10258 (100.0 %) 1.0 1.0
New Zealand, Polynesia, Micronesia, or Melanesia 23 (4.6 %) 503 (100.0 %) 0.7 (0.5, 1.2) 0.289 0.7 (0.5, 1.2) 0.193
Central, East, South or South-East Asia 35 (3.0 %) 1175 (100.0 %) 0.5 (0.4, 0.7) <0.001 0.7 (0.5, 1.1) 0.098
Middle-East (West Asia) or Africa 14 (3.6 %) 387 (100.0 %) 0.6 (0.4, 1.1) 0.085 0.8 (0.4, 1.3) 0.356
Europe or North America 54 (5.3 %) 1025 (100.0 %) 0.9 (0.7, 1.2) 0.575 0.8 (0.6, 1.2) 0.315
South America, Central America or Caribbean 0 (0.0 %) 64 (100.0 %) -
Marital status
Never married 121 (3.4 %) 3508 (100.0 %) 1.0 1.0
Widowed/divorced/separated 63 (7.3 %) 865 (100.0 %) 2.2 (1.6, 3.0) <0.001 1.2 (0.8, 1.8) 0.297
Married/de facto relationship 522 (5.8 %) 8950 (100.0 %) 1.7 (1.4, 2.1) <0.001 1.2 (0.9, 1.5) 0.278
Highest Educational Level
Completed secondary school or less 176 (5.4 %) 3279 (100.0 %) 1.0 1.0
Tertiary certificate, diploma, trade qualifications or
other similar qualifications
341 (5.7 %) 6020 (100.0 %) 1.0 (0.9, 1.3) 0.550 0.9 (0.8, 1.2) 0.513
Graduate or post-graduate 149 (4.5 %) 3299 (100.0 %) 0.8 (0.7, 1.0) 0.112 1.0 (0.8, 1.3) 0.906
Employment Status
Employed 566 (5.0 %) 11286 (100.0 %) 1.0 1.0
Unemployed and looking for work 58 (5.3 %) 1093 (100.0 %) 1.1 (0.8, 1.4) 0.674 1.2 (0.9, 1.7) 0.265
Neither working nor looking for work 77 (9.9 %) 777 (100.0 %) 2.1 (1.6, 2.7) <0.001 1.9 (1.5, 2.6) <0.001
Number of hours worked per week
Up to 20 h 27 (4.0 %) 681 (100.0 %) 1.00 1.00
21–40 h 205 (4.7 %) 4377 (100.0 %) 1.2 (0.8, 1.8) 0.405 1.0 (0.6, 1.5) 0.896
More than 40 h 257 (5.1 %) 5054 (100.0 %) 1.3 (0.9, 1.9) 0.207 1.0 (0.6, 1.5) 0.860
Main job has night shift
No 418 (4.9 %) 8536 (100.0 %) 1.0 1.0
Yes 138 (5.3 %) 2595 (100.0 %) 1.1 (0.9, 1.3) 0.389 1.1 (0.8, 1.3) 0.611
aAdjusted for age, country of birth and BMI
bRow percentages
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with the younger age distribution in our sample. Other lit-
erature, however, suggests that obstructive sleep apnoea is
a risk factor for heart failure [54–56] concurring with our
findings. It is also possible that some of the reported doc-
tor-/health professional- diagnosed sleep apnoea in our
study is central sleep apnoea (rather than obstructive
sleep apnoea), which is known to be a consequence of
heart failure [56]. However, 60–78 % of sleep apnoea in
heart failure is reported in recent studies to be ob-
structive sleep apnoea [57, 58].
The associations we found between sleep apnoea and
other co-morbidities also confirm the positive associa-
tions of obstructive sleep apnoea which previously have
been reported for cardiovascular diseases [55, 59–63],
metabolic disorders [64–68], and psychiatric disorders
[69–72]. Although the association with schizophrenia
(OR 2.9) is difficult to interpret due to the wide confi-
dence interval, the association with depression and anx-
iety disorders (OR 2.7) are robust and may indicate an
impending compound burden on the healthcare system
as the prevalence of these latter diseases themselves are
high and increasing [73–77].
The association between doctor-/health professional-
diagnosed sleep apnoea and stroke in our study, never-
theless, was not significant after adjusting for age,
country of birth, and BMI. Even with similar adjustments,
the significant association between the obstructive sleep
apnoea and stroke had remained in the Sleep Heart Health
Study participants [78]. Participants in that study, how-
ever, were aged approximately 50 years or more when this
association was assessed. As stroke is more a disease of
older ages [79–81], inclusion of younger men in our study
as well as inadequate power to detect an association due
to the low frequency of stroke would have attenuated its
association with sleep apnoea.
Our study also adds to the existing evidence on some
putative associations. The previous evidence for the as-
sociation between smoking and obstructive sleep apnoea
has been equivocal, the positive association found by
smaller studies [82–84] being disputed by findings of
Table 3 Associations between self-reported comorbidities and sleep apnoea
Co-morbidities Lifetime doctor- or other health professional-
diagnosed sleep apnoea status
Mean (SD)





Eczema 103 (7.4 %) 1395 (100.0 %) 1.5 (1.2, 1.9) <0.001 1.6 (1.3, 2.0) <0.001
Asthma 194 (6.6 %) 2944 (100.0 %) 1.4 (1.2, 1.6) <0.001 1.3 (1.0, 1.6) 0.011
COPD or chronic bronchitis 72 (10.5 %) 683 (100.0 %) 2.3 (1.8, 3.0) <0.001 1.6 (1.2, 2.1) 0.002
Diabetes 87 (18.2 %) 477 (100.0 %) 4.4 (3.5, 5.7) <0.001 2.4 (1.8, 3.2) <0.001
High cholesterol 220 (10.0 %) 2202 (100.0 %) 2.5 (2.1, 2.9) <0.001 1.7 (1.4, 2.1) <0.001
High blood pressure 235 (10.7 %) 2197 (100.0 %) 2.7 (2.3, 3.2) <0.001 1.6 (1.4, 2.0) <0.001
Heart attack 34 (21.7 %) 157 (100.0 %) 5.2 (3.5, 7.7) <0.001 2.8 (1.8, 4.4) <0.001
Heart failure 23 (28.8 %) 80 (100.0 %) 7.6 (4.6, 124) <0.001 4.5 (2.6, 8.0) <0.001
Angina 29 (17.8 %) 163 (100.0 %) 4.1 (2.7, 6.1) <0.001 2.6 (1.6, 4.1) <0.001
Stroke 13 (15.1 %) 86 (100.0 %) 3.3 (1.8, 6.0) <0.001 1.9 (0.9, 3.9) 0.096
Depression 297 (11.3 %) 2629 (100.0 %) 3.2 (2.8, 3.8) <0.001 2.7 (2.3, 3.2) <0.001
PTSD 63 (14.6 %) 433 (100.0 %) 3.3 (2.5, 4.4) <0.001 2.6 (1.9, 3.5) <0.001
Other anxiety disorders 183 (11.7 %) 1567 (100.0 %) 2.9 (2.4, 3.5) <0.001 2.7 (2.2, 3.3) <0.001
Schizophrenia 14 (14.9 %) 94 (100.0 %) 3.2 (1.8, 5.7) <0.001 2.9 (1.5, 5.7) 0.002
Cancer 34 (9.3 %) 366 (100.0 %) 1.9 (1.3, 2.8) <0.001 1.4 (0.9, 1.2) 0.092
BMI category (kg/m2)
Normal or underweight (up to 24.9) 81 (2.1 %) 3910 (100.0 %) 1.0
Overweight (25.0–29.9) 224 (4.4 %) 5062 (100.0 %) 2.2 (1.7, 2.8) <0.001 1.7 (1.4, 2.4) <0.001
Obese 1 (30.0–34.9) 167 (8.6 %) 1951 (100.0 %) 4.4 (3.4, 5.8) <0.001 3.6 (2.7, 4.7) <0.001
Obese 2(35.0–39.9) 93 (15.4 %) 606 (100.0 %) 8.6 (6.3, 11.7) <0.001 7.0 (5.1, 9.6) <0.001
Obese 3(> = 40) 58 (20.7 %) 280 (100.0 %) 12.4 (8.6, 17.8) <0.001 10.3 (7.1, 14.9) <0.001
aAdjusted for age, country of birth and BMI
bRow percentages
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much larger studies [85]. Overall, the evidence favours a
positive association, and our findings confirm this. Similar
conflicts of evidence exist with regard to the association
between obstructive sleep apnoea and alcohol consump-
tion [38, 86–89], which overall favours a positive associ-
ation, again concurring with our findings.
Conclusion
The estimated prevalence of doctor-/health professional-
diagnosed sleep apnoea and its associations with cardio-
vascular, metabolic, respiratory, and psychiatric disorders
have important clinical and public health implications
for Australia. As men are especially vulnerable to some
of the chronic diseases that are associated with sleep ap-
noea, they represent a relevant group for targeted health
interventions. While it is not possible to make any direct
causal inferences from our study, it is reasonable to con-
sider modifiable lifestyle-related factors such as smoking,
alcohol consumption, level of physical activity and BMI
to be potential foci for such interventions. These find-
ings may help inform public health policy and clinical
disease screening protocols.
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Table 4 Associations of lifestyle factors and health-related behaviour with sleep apnoea
Characteristic Proportion with lifetime sleep apnoea status OR (95 % CI) p Adjusteda OR (95 % CI) p
Sleep apnoea Total
Lifestyle-related factors N (%b)
Level of Physical activity
Sufficient 352 (4.5 %) 7773 (100.0 %) 1.0 1.0
Sedentary/Insufficient 304 (7.0 %) 4330 (100.0 %) 1.6 (1.4, 1.9) <0.001 1.3 (1.1, 1.5) 0.006
Sitting time
< 6 h per day 277 (4.7 %) 5949 (100.0 %) 1.0 1.0
> = 6 h per day 318 (5.7 %) 5590 (100.0 %) 1.2 (1.0, 1.5) 0.012 1.2 (1.0, 1.4) 0.036
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6–10 pack-years 49 (4.8 %) 1014 (100.0 %) 1.1 (0.8, 1.5) 0.466 1.0 (0.7, 1.4) 0.971
11–20 pack-years 103 (8.0 %) 1290 (100.0 %) 1.9 (1.5, 2.4) <0.001 1.6 (1.3, 2.1) <0.001
21–40 pack-years 86 (7.6 %) 1139 (100.0 %) 1.8 (1.4, 2.3) <0.001 1.2 (0.9, 1.6) 0.167
> 40 pack-years 47 (13.3 %) 354 (100.0 %) 3.4 (2.4, 6.7) <0.001 1.9 (1.3, 2.8) 0.001
Alcohol use months
Low (<8) 433 (5.0 %) 8660 (100.0 %) 1.0 1.0
Medium (8–15) 184 (5.2 %) 3515 (100.0 %) 1.0 (0.9, 1.2) 0.593 1.1 (0.9, 1.3) 0.291
High (> = 16) 87 (7.6 %) 1137 (100.0 %) 1.6 (1.2, 2.0) <0.001 1.7 (1.3, 2.2) <0.001
aAdjusted for age, country of birth and BMI
bRow percentages
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